CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-25
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-03-31 was $400.00K, a 300.00% increase year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-12-31 was $1.90M.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-09-30 was $2.80M, a 2700.00% increase year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-06-30 was $100.00K, a 0.00% change year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $1.50M, a 68.75% decline from fiscal 2024.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $4.80M, a 4700.00% increase from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $100.00K, a 93.75% decline from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $1.60M, a 96.27% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-02-25 | |||||
| 2025-03-31 | $400.00K 10-Q · filed 2025-04-30 | $2.30M derived: sum of 2 quarters · filed 2026-02-25 | $5.10M derived: sum of 3 quarters · filed 2026-02-25 | $5.20M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.70M derived: sum of 2 quarters · filed 2026-02-25 | $4.80M derived: sum of 3 quarters · filed 2026-02-25 | $4.80M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-04 | $2.90M derived: sum of 2 quarters · filed 2024-11-04 | $2.90M 10-Q · filed 2024-11-04 | $3.00M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $100.00K 10-Q · filed 2024-07-31 | $100.00K 10-Q · filed 2024-07-31 | $200.00K derived: sum of 3 quarters · filed 2026-02-25 | $300.00K derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $100.00K 10-Q · filed 2025-04-30 | $100.00K derived: sum of 2 quarters · filed 2026-02-25 | $200.00K derived: sum of 3 quarters · filed 2026-02-25 | $300.00K derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $100.00K derived: sum of 2 quarters · filed 2026-02-25 | $200.00K derived: sum of 3 quarters · filed 2026-02-25 | $100.00K 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $100.00K 10-Q · filed 2024-11-04 | $74.00K 10-Q · filed 2023-11-08 | $200.00K derived: sum of 2 quarters · filed 2024-11-04 | $100.00K 10-Q · filed 2024-11-04 | $600.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $100.00K 10-Q · filed 2024-07-31 | $19.00K 10-Q · filed 2023-08-08 | $100.00K 10-Q · filed 2024-07-31 | $31.00K 10-Q · filed 2023-08-08 | $500.00K derived: sum of 3 quarters · filed 2025-02-28 | $600.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $0.00 10-Q · filed 2023-05-10 | $400.00K derived: sum of 2 quarters · filed 2025-02-28 | $500.00K derived: sum of 3 quarters · filed 2025-02-28 | $800.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $400.00K derived: sum of 2 quarters · filed 2025-02-28 | $700.00K derived: sum of 3 quarters · filed 2025-02-28 | $1.60M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-08 | $400.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.30M 10-Q · filed 2023-11-08 | $5.10M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-08 | $1.30M 10-Q · filed 2023-08-08 | $5.00M derived: sum of 3 quarters · filed 2024-02-28 | $9.20M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-10 | $4.70M derived: sum of 2 quarters · filed 2024-02-28 | $8.90M derived: sum of 3 quarters · filed 2024-02-28 | $34.80M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $7.90M derived: sum of 2 quarters · filed 2024-02-28 | $33.80M derived: sum of 3 quarters · filed 2024-02-28 | $42.90M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $4.20M 10-Q · filed 2022-11-03 | $30.10M derived: sum of 2 quarters · filed 2022-11-03 | $39.20M 10-Q · filed 2022-11-03 | $50.40M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-06-30 | $25.90M 10-Q · filed 2022-08-04 | $35.00M 10-Q · filed 2022-08-04 | $46.20M derived: sum of 3 quarters · filed 2023-02-27 | $50.20M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2021-03-31 | $9.10M 10-Q · filed 2022-05-05 | $20.30M derived: sum of 2 quarters · filed 2023-02-27 | $24.30M derived: sum of 3 quarters · filed 2023-02-27 | $27.60M derived: sum of 4 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $11.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $15.20M derived: sum of 2 quarters · filed 2023-02-27 | $18.50M derived: sum of 3 quarters · filed 2023-02-27 | $19.20M 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $4.00M 10-Q · filed 2021-10-28 | $7.30M derived: sum of 2 quarters · filed 2021-10-28 | $8.00M 10-Q · filed 2021-10-28 | $8.80M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-30 | $3.30M 10-Q · filed 2021-07-29 | $4.00M 10-Q · filed 2021-07-29 | $4.80M derived: sum of 3 quarters · filed 2022-02-24 | $7.10M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-31 | $700.00K 10-Q · filed 2021-05-05 | $1.50M derived: sum of 2 quarters · filed 2022-02-24 | $3.80M derived: sum of 3 quarters · filed 2022-02-24 | $9.80M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.10M derived: sum of 2 quarters · filed 2022-02-24 | $9.10M derived: sum of 3 quarters · filed 2022-02-24 | $15.10M 10-K · filed 2022-02-24 | ||
| 2019-09-30 | $2.30M 10-Q · filed 2020-10-29 | $8.30M derived: sum of 2 quarters · filed 2020-10-29 | $14.30M 10-Q · filed 2020-10-29 | $18.50M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $6.00M 10-Q · filed 2020-08-04 | $12.00M 10-Q · filed 2020-08-04 | $16.20M derived: sum of 3 quarters · filed 2021-02-24 | $17.90M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $6.00M 10-Q · filed 2020-04-30 | $10.20M derived: sum of 2 quarters · filed 2021-02-24 | $11.90M derived: sum of 3 quarters · filed 2021-02-24 | $12.10M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $5.90M derived: sum of 2 quarters · filed 2021-02-24 | $6.10M derived: sum of 3 quarters · filed 2021-02-24 | $6.80M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.90M derived: sum of 2 quarters · filed 2018-11-08 | $2.60M 10-Q · filed 2018-11-08 | $2.80M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $900.00K 10-Q · filed 2018-08-09 | $1.10M derived: sum of 3 quarters · filed 2020-02-28 | $1.10M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $700.00K 10-Q · filed 2018-05-10 | $900.00K derived: sum of 2 quarters · filed 2020-02-28 | $900.00K derived: sum of 3 quarters · filed 2020-02-28 | $900.00K derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $200.00K derived: sum of 2 quarters · filed 2020-02-28 | $200.00K derived: sum of 3 quarters · filed 2020-02-28 | $200.00K 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2017-06-09 | |||||
| 2016-12-31 | $7.10K 10-K · filed 2017-04-21 | |||||
| 2015-12-31 | $89.00K 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |